MOBIA MEDICAL, INC. Cost of Revenue
MOBIA MEDICAL, INC. (MOBI) reported Cost of Revenue of $2.27 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-11
- MOBIA MEDICAL, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $2.27M, a 91.47% increase year-over-year.
- MOBIA MEDICAL, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $2.13M, a 110.15% increase year-over-year.
- MOBIA MEDICAL, INC. cost of goods and services sold for the quarter ending 2025-06-30 was $1.18M.
- MOBIA MEDICAL, INC. cost of goods and services sold for the quarter ending 2025-03-31 was $1.01M.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month |
|---|---|---|
| 2026-06-30 | $2.27M 10-Q · filed 2026-08-11 | $4.40M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $2.13M 10-Q · filed 2026-06-04 | |
| 2025-06-30 | $1.18M 10-Q · filed 2026-08-11 | $2.20M 10-Q · filed 2026-08-11 |
| 2025-03-31 | $1.01M 10-Q · filed 2026-06-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B |